Orthofix Medical Inc. Financial Ratios — OFIX Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	-5.97	13.22	-8.83	-2.87	-0.95	1.1	2.22	4.37	-8.59	0.74	-11.06	-5.86	-32.36	-22.87	-19.34
Return on Assets (%)	-2.75	7.45	-6.57	-2.12	-0.71	0.79	1.6	3.17	-5.92	0.49	-7.66	-4.22	-21.88	-13.86	-10.57
Return on Capital (%)	- -	9.76	- -	-2.77	-0.95	1.1	2.22	4.53	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	11.54	- -	-3.29	-1.76	2.39	2.95	6.67	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	77.86	77.12	73.11	75.41	78.18	78.56	78.55	78.67	78.13	74.94	75.26	73.18	65.13	68.28	68.83
EBITDA Margin (%)	19.96	22.01	11.01	13.83	9.9	13.73	14.05	11.94	8.44	5.09	7.42	0.7	-10.88	-0.22	0.08
Operating Margin (%)	14.64	17.3	5.27	8.14	4.63	8.65	9.41	7.6	2.25	-3.34	0.29	-6.27	-18.99	-9.72	-10.04
Incremental Operating Margin (%)	8.25	265.85	129.69	252.98	249	128.57	22.36	-33.26	-348.07	- -	25.78	- -	- -	- -	- -
Pretax Margin (%)	-0.31	15.69	-2.67	3.1	2.15	4.64	8.39	5.05	-5.88	-0.09	-2.91	-3.84	-19.91	-15.49	-11.04
Profit Margin (%)	-4.06	9.73	-7.25	-2.12	-0.71	0.75	1.43	3.05	-6.19	0.62	-8.26	-4.29	-20.28	-15.76	-11.21
Net Income to Common Margin (%)	-4.06	9.73	-7.25	-2.12	-0.71	0.75	1.43	3.05	-6.19	0.62	-8.26	-4.29	-20.28	-15.76	-11.21
Effective Tax Rate (%)	- -	34.67	- -	130.06	127.53	81.62	79.96	39.65	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	-5.97	13.22	-8.83	-2.87	-0.95	1.1	2.22	4.37	-8.59	0.74	-11.06	-5.86	-32.36	-22.87	-19.34

Credit (USD)

Credit Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	210	20	20	- -	- -	- -	- -	- -	23	25	24	22	117	180	178
ST Debt	19	- -	- -	- -	- -	- -	- -	- -	2	3	4	2	5	5	4
LT Debt	191	20	20	- -	- -	- -	- -	- -	21	22	20	19	112	175	174
Total Debt/EBITDA	2.42	0.21	0.46	- -	- -	- -	- -	- -	0.59	1.2	0.71	6.71	-1.44	-102.24	259.73
Net Debt/EBITDA	2.03	-0.11	-0.2	-0.66	-1.62	-0.7	-1.33	-1.29	-1.8	-4.65	-2.55	-15.81	-0.75	-41.99	109.7
Total Debt/EBIT	3.29	0.26	0.95	- -	- -	- -	- -	- -	2.21	-1.84	17.8	-0.75	-0.83	-2.31	-2.16
Net Debt/EBIT	2.77	-0.14	-0.43	-1.12	-3.47	-1.12	-1.99	-2.02	-6.73	7.1	-64.31	1.76	-0.43	-0.95	-0.91
EBITDA to Interest Expense	8.88	- -	- -	- -	- -	- -	- -	65.34	318.3	8.34	18.76	2.49	-9.41	-0.06	0.04
EBITDA-CapEx/Interest Expense	8.88	- -	- -	- -	- -	- -	- -	65.34	318.3	8.34	18.76	2.49	-9.41	-0.06	0.04
EBIT to Interest Expense	6.51	- -	- -	- -	- -	- -	- -	41.57	84.89	-5.46	0.74	-22.41	-16.42	-2.62	-4.72
Interest Expense	10	- -	- -	- -	- -	- -	- -	1	- -	2	2	1	9	30	17
Common Equity/Total Assets	42.61	76.73	71.82	76.25	72.54	70.81	73.17	71.87	66.11	67.86	70.69	73.45	64.71	56.32	52.91
Long-Term Debt/Equity (%)	65.46	5.61	6.76	- -	- -	- -	- -	- -	6.3	6.26	5.9	5.71	18.65	34.75	38.76
Long-Term Debt/Capital (%)	38.08	5.31	6.33	- -	- -	- -	- -	- -	5.89	5.85	5.51	5.37	15.6	25.61	27.76
Long-Term Debt/Total Assets (%)	27.9	4.31	4.85	- -	- -	- -	- -	- -	4.17	4.25	4.17	4.19	12.06	19.57	20.51
Total Debt/Equity (%)	71.9	5.62	6.76	- -	- -	- -	- -	- -	6.97	6.99	7.22	6.39	19.55	35.7	39.65
Total Debt/Capital (%)	41.83	5.32	6.33	- -	- -	- -	- -	- -	6.52	6.53	6.73	6.01	16.36	26.31	28.39
Total Debt/Total Assets (%)	30.64	4.31	4.85	- -	- -	- -	- -	- -	4.61	4.74	5.1	4.69	12.65	20.11	20.98
Net Debt to Equity	60.53	-3.02	-3.02	-12.29	-21.93	-15.02	-27.36	-20.76	-21.28	-26.98	-26.07	-15.05	10.23	14.66	16.75
Net Debt/Capital (%)	37.71	-3.11	-3.11	-14.01	-28.09	-17.67	-37.67	-26.2	-24.83	-33.73	-32.13	-16.48	8.97	12.31	13.79
EBITDA	87	97	44	56	39	56	61	54	39	21	34	3	-81	-2	1
EBITDA-CapEx	87	97	44	56	39	56	61	54	39	21	34	3	-81	-2	1
Operating Income (Loss)	64	76	21	33	18	35	41	34	10	-14	1	-29	-142	-78	-83

Liquidity (USD)

Liquidity Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	0.18	0.47	0.41	0.55	0.78	0.47	1.02	0.81	0.82	0.93	0.83	0.61	0.2	0.49	0.48
Current Ratio	2.89	4.6	3.77	3.3	2.59	2.33	3.17	2.85	3.07	2.6	2.55	3.06	2.54	2.57	2.45
Quick Ratio	0.95	2.06	1.42	1.48	1.51	1.17	1.82	1.72	1.84	1.62	1.57	1.6	0.98	1.29	1.28
CFO/Avg Current Liab	0.48	0.08	0.99	0.75	0.59	0.71	0.48	0.6	0.38	0.79	0.18	-0.12	-0.37	0.15	0.2
Common Equity/Total Assets	42.61	76.73	71.82	76.25	72.54	70.81	73.17	71.87	66.11	67.86	70.69	73.45	64.71	56.32	52.91
Long-Term Debt/Equity (%)	65.46	5.61	6.76	- -	- -	- -	- -	- -	6.3	6.26	5.9	5.71	18.65	34.75	38.76
Long-Term Debt/Capital (%)	38.08	5.31	6.33	- -	- -	- -	- -	- -	5.89	5.85	5.51	5.37	15.6	25.61	27.76
Long-Term Debt/Total Assets (%)	27.9	4.31	4.85	- -	- -	- -	- -	- -	4.17	4.25	4.17	4.19	12.06	19.57	20.51
Total Debt/Equity (%)	71.9	5.62	6.76	- -	- -	- -	- -	- -	6.97	6.99	7.22	6.39	19.55	35.7	39.65
Total Debt/Capital (%)	41.83	5.32	6.33	- -	- -	- -	- -	- -	6.52	6.53	6.73	6.01	16.36	26.31	28.39
Total Debt/Total Assets (%)	30.64	4.31	4.85	- -	- -	- -	- -	- -	4.61	4.74	5.1	4.69	12.65	20.11	20.98
CFO/Total Liabilities	16.46	9.4	57.74	54.82	39.68	54.38	35.84	38.03	19.07	43.95	13.23	-9.48	-14.01	6.61	8.32
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	2.92	7.14	4.44	5.96	6.05	5.97	8.08	7.03	5.26	4.65	4.62	3.73	1.53	1.82	1.47

Working Capital (USD)

Working Capital Ratios API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	3.72	4.32	4.55	6.09	6.54	6.96	7.15	6.42	5.59	5.11	6.15	5.71	7.08	6.08	6.08
Days Sales Outstanding	98.09	84.45	80.15	59.96	55.79	52.41	51.02	56.87	65.29	71.48	59.32	63.94	51.56	59.99	60.02
Inventory Turnover	1.16	1.33	1.5	1.49	1.47	1.45	1.29	1.22	1.26	1.22	1.37	1.35	1.62	1.23	1.42
Days Inventory Outstanding	314.44	274.21	243.23	244.52	247.64	251.17	283.79	298.75	288.87	299.18	266.19	270.51	225.92	296.21	257.61
Accounts Payable Turnover	4.91	4.36	5.08	5.08	5.69	6.09	6.84	5.1	5.61	4.84	4.57	5.21	8.9	4.12	4.46
Accounts Payable Turnover Days	74.34	83.66	71.9	71.87	64.16	59.92	53.37	71.5	65.11	75.37	79.89	70.11	41.02	88.54	81.8
Cash Conversion Cycle	338.18	274.99	251.48	232.61	239.27	243.66	281.45	284.12	289.04	295.29	245.62	264.35	236.46	267.67	235.83
Inventory to Cash Days	-216.35	-189.76	-163.09	-184.56	-191.86	-198.76	-232.77	-241.87	-223.58	-227.71	-206.86	-206.57	-174.36	-236.22	-197.58
Inventories	82	70	73	60	58	63	81	77	82	85	83	100	222	189	172
Raw Materials	10	8	7	4	5	8	6	8	10	8	10	17	28	27	23
Work In Process	6	8	7	5	5	10	12	13	14	12	15	19	54	57	63
Finished Goods	57	44	52	46	43	42	60	55	59	64	58	64	140	105	86
Other Inventory	38	11	8	6	5	3	2	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

Enterprise Value API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	651	761	413	559	732	645	1,000	975	878	835	617	414	501	672	604
- Cash & Cash Equivalents	33	31	29	37	64	40	81	70	70	96	88	51	33	83	82
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	210	20	20	- -	- -	- -	- -	- -	23	25	24	22	117	180	178
Enterprise Value	827	750	404	523	668	605	919	906	832	763	553	385	585	768	700
Total Capital	502	376	316	300	290	263	297	335	350	382	361	358	716	683	628
Total Debt/Capital (%)	41.83	5.32	6.33	- -	- -	- -	- -	- -	6.52	6.53	6.73	6.01	16.36	26.31	28.39
Total Debt / EV	0.25	0.03	0.05	- -	- -	- -	- -	- -	0.03	0.03	0.04	0.06	0.2	0.23	0.25
EV/Sales	1.9	1.7	1.02	1.3	1.68	1.48	2.12	2	1.81	1.88	1.19	0.84	0.78	0.96	0.85
EV/EBITDA	9.52	7.74	9.23	9.4	17.01	10.76	15.08	16.74	21.41	36.87	16.05	119.97	- -	- -	1,019.35
EV/EBIT	12.98	9.85	19.3	15.96	36.43	17.09	22.51	26.31	80.3	- -	404.98	- -	- -	- -	- -
EV/Cash Flow to Firm	4.64	73.79	6.03	10.22	15.32	10.25	23.57	17.96	25.86	13.33	23.34	- -	- -	13.74	13.7
EV/Free Cash Flow to Firm	4.64	73.79	6.03	10.22	15.32	10.25	23.57	17.96	25.86	13.33	23.34	- -	- -	13.74	13.7
Diluted Market Cap	642	763	427	555	737	668	1,012	993	873	833	612	413	495	665	600
Diluted Enterprise Value	819	752	418	518	673	628	931	923	826	762	549	383	579	762	697
EV per Share	44.8	38.77	22.33	28.08	35.8	33.96	50.26	48.74	43.72	39.31	27.89	19.08	15.74	19.96	17.58
TTM Sales	436	440	398	402	396	410	434	453	460	407	464	461	747	799	822
TTM EBITDA	87	97	44	56	39	56	61	54	39	21	34	3	-81	-2	1
TTM Operating Income	64	76	21	33	18	35	41	34	10	-14	1	-29	-142	-78	-83
TTM Cash Flow to Firm	178	10	67	51	44	59	39	50	32	57	24	-10	-37	56	51
TTM Free Cash Flow to Firm	178	10	67	51	44	59	39	50	32	57	24	-10	-37	56	51

Multiples (USD)

Valuation Multiples API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	9.92	75.05	6.36	10.85	16.9	11.31	25.96	19.89	27.25	11.22	33.14	-35.76	-10.82	25.79	18
EV/EBIT	12.98	9.85	19.3	15.96	36.43	17.09	22.51	26.31	80.3	- -	404.98	- -	- -	- -	- -
Enterprise Value	827	750	404	523	668	605	919	906	832	763	553	385	585	768	700
Low Price	28.09	34.02	19.35	20.23	28.05	32.51	33.51	48	39.75	22.11	28.64	13.76	9.57	12.08	10.24
EV/Sales	1.9	1.7	1.02	1.3	1.68	1.48	2.12	2	1.81	1.88	1.19	0.84	0.78	0.96	0.85
EV/EBITDA	9.52	7.74	9.23	9.4	17.01	10.76	15.08	16.74	21.41	36.87	16.05	119.97	- -	- -	1,019.35
Price/Earnings	- -	17.42	- -	- -	- -	214.81	159.25	70.29	- -	329.02	- -	- -	- -	- -	- -
Price/Earnings Average	-36.13	17.66	-18.2	-63.86	-232.4	245.52	129.25	75.62	-34.49	266.62	-20.44	-25.62	-4.12	-4.61	-6.25
Price/Earnings High	-45.88	20.2	-26.6	-79.79	-285.11	286.47	164.58	85.13	-49.44	366.76	-24.88	-36.77	-5.63	-6.27	-8.8
Price/Earnings Low	-28.92	15.07	-12.56	-43.74	-187.68	193.02	97.56	64.28	-26.4	169.25	-14.7	-14	-2.32	-3.65	-4.4
Price/Book Value	2.23	2.13	1.4	1.87	2.52	2.45	3.37	2.91	2.68	2.34	1.83	1.23	0.84	1.34	1.34
Price/Book Value Average	2.22	2.16	1.72	1.83	2.23	2.8	2.74	3.13	3.01	1.9	2.35	1.51	1.05	1.17	1.29
Price/Book Value High	2.82	2.48	2.51	2.29	2.74	3.26	3.48	3.52	4.32	2.61	2.86	2.16	1.44	1.59	1.81
Price/Book Value Low	1.78	1.85	1.18	1.26	1.8	2.2	2.07	2.66	2.31	1.2	1.69	0.82	0.59	0.92	0.91
Price/Tangible Book Value	3.1	2.77	1.77	2.34	3.16	3.19	4.3	4.62	4.34	3.93	2.9	1.9	1.75	3.21	3.31
Price/Tangible Book Value Average	3.08	2.81	2.18	2.3	2.8	3.64	3.49	4.97	4.88	3.19	3.71	2.33	2.2	2.8	3.18
Price/Tangible Book Value High	3.92	3.21	3.18	2.87	3.44	4.25	4.44	5.6	7	4.38	4.52	3.34	3.01	3.81	4.47
Price/Tangible Book Value Low	2.47	2.39	1.5	1.58	2.26	2.86	2.63	4.22	3.74	2.02	2.67	1.27	1.24	2.22	2.24
Price/Sales	1.47	1.7	1.07	1.38	1.86	1.6	2.28	2.14	1.9	2.04	1.32	0.9	0.66	0.83	0.73
Price/Sales Average	1.47	1.72	1.32	1.36	1.65	1.83	1.85	2.31	2.13	1.65	1.69	1.1	0.84	0.73	0.7
Price/Sales High	1.86	1.97	1.93	1.69	2.02	2.14	2.36	2.6	3.06	2.27	2.06	1.58	1.14	0.99	0.99
Price/Sales Low	1.18	1.47	0.91	0.93	1.33	1.44	1.4	1.96	1.63	1.05	1.21	0.6	0.47	0.58	0.49
Price/Cash Flow	9.92	73.45	6.36	10.85	16.9	11.11	25.43	19.45	27.25	11.15	33.14	-35.76	-10.82	25.79	18
Price/Cash Flow Average	9.88	74.47	7.82	10.66	14.97	12.7	20.64	20.92	30.64	9.04	42.46	-43.85	-13.63	22.54	17.28
Price/Cash Flow High	12.54	85.19	11.43	13.31	18.36	14.82	26.28	23.55	43.93	12.43	51.69	-62.93	-18.62	30.62	24.32
Price/Cash Flow Low	7.91	63.53	5.4	7.3	12.09	9.98	15.58	17.78	23.46	5.74	30.53	-23.97	-7.69	17.85	12.16
Price/Free Cash Flow Average	9.88	76.1	7.82	10.66	14.97	12.92	21.07	21.39	30.64	9.09	42.46	-43.85	-13.63	22.54	17.28
Price/Free Cash Flow High	12.54	87.05	11.43	13.31	18.36	15.08	26.83	24.08	43.93	12.51	51.69	-62.93	-18.62	30.62	24.32
Price/Free Cash Flow Low	7.91	64.91	5.4	7.3	12.09	10.16	15.91	18.18	23.46	5.77	30.53	-23.97	-7.69	17.85	12.16
EV/Sales Average	1.89	1.73	1.25	1.27	1.47	1.7	1.68	2.16	2.05	1.49	1.56	1.04	0.96	0.86	0.82
EV/Sales High	2.3	1.98	1.84	1.62	1.84	2	2.19	2.45	2.98	2.11	1.93	1.52	1.27	1.12	1.11
EV/Sales Low	1.6	1.47	0.86	0.84	1.16	1.32	1.22	1.81	1.54	0.88	1.09	0.54	0.59	0.7	0.61
EV/EBITDA Average	9.49	7.85	11.39	9.22	14.89	12.4	11.99	18.11	24.23	29.22	21.09	149.15	-8.81	-389.05	984.25
EV/EBITDA High	11.5	8.99	16.75	11.68	18.63	14.58	15.63	20.54	35.26	41.49	26.07	218.02	-11.65	-508.94	1,327.82
EV/EBITDA Low	8	6.68	7.8	6.11	11.71	9.6	8.72	15.2	18.26	17.29	14.65	77.41	-5.42	-319.47	734.08
EV/EBIT Average	12.94	9.98	23.81	15.66	31.87	19.69	17.9	28.46	90.85	-44.61	532.01	-16.57	-5.04	-8.8	-8.19
EV/EBIT High	15.68	11.44	35	19.85	39.89	23.16	23.33	32.29	132.21	-63.34	657.8	-24.22	-6.67	-11.51	-11.05
EV/EBIT Low	10.91	8.5	16.3	10.37	25.07	15.24	13.02	23.89	68.49	-26.4	369.47	-8.6	-3.1	-7.22	-6.11
Last Price	35.23	39.33	22.82	30.06	39.21	36.18	54.7	52.49	46.18	42.98	31.09	20.53	13.48	17.46	15.16
High Price	44.57	45.62	40.99	36.9	42.61	48.25	56.53	63.57	74.44	47.91	48.5	36.12	23.19	20.73	20.48
Enterprise Value Average	825	760	499	513	584	698	730	980	941	605	727	478	715	684	676
Enterprise Value High	1,000	872	733	650	731	821	952	1,111	1,369	859	899	699	946	894	912
Enterprise Value Low	696	647	341	340	460	540	531	822	709	358	505	248	440	561	504

Shares Outstanding	18	19	18	19	19	18	18	19	19	19	20	20	37	38	40
Diluted Weighted Avg Shares	18	19	19	18	19	18	18	19	19	19	20	20	37	38	40
Basic Weighted Avg Shares	18	19	19	18	19	18	18	18	19	19	20	20	37	38	40
Revenue per Share	23.9	23.2	21.27	21.79	21.1	22.59	23.95	24.5	24.33	21.1	23.59	22.92	20.33	20.98	20.77
EBITDA per Share	4.77	5.11	2.34	3.01	2.09	3.1	3.36	2.93	2.05	1.07	1.75	0.16	-2.21	-0.05	0.02
Operating Income per Share	3.5	4.01	1.12	1.77	0.98	1.95	2.25	1.86	0.55	-0.7	0.07	-1.44	-3.86	-2.04	-2.09
Basic EPS, GAAP	-0.97	2.26	-1.54	-0.46	-0.15	0.17	0.34	0.75	-1.51	0.13	-1.95	-0.98	-4.12	-3.31	-2.33
Basic EPS from Cont Ops	-0.87	2.38	-0.97	-0.2	-0.12	0.19	0.4	0.75	-1.51	0.13	-1.95	-0.98	-4.12	-3.31	-2.33
Diluted EPS, GAAP	-0.97	2.21	-1.54	-0.46	-0.15	0.17	0.34	0.73	-1.51	0.13	-1.95	-0.98	-4.12	-3.31	-2.33
Diluted EPS from Cont Ops	-0.87	2.33	-0.97	-0.2	-0.12	0.19	0.39	0.73	-1.51	0.13	-1.95	-0.98	-4.12	-3.31	-2.33
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	3.55	0.54	3.59	2.77	2.32	3.26	2.15	2.7	1.69	3.85	0.94	-0.57	-1.25	0.68	0.84
Free Cash Flow per Basic Share	3.55	0.54	3.59	2.77	2.32	3.26	2.15	2.7	1.69	3.85	0.94	-0.57	-1.25	0.68	0.84
Cash & Equivalents per Share	1.8	1.59	1.6	1.98	3.41	2.22	4.44	3.75	3.67	4.96	4.43	2.51	0.89	2.16	2.06
Book Value per Share	15.82	18.43	16.34	16.1	15.56	14.78	16.23	18.05	17.22	18.37	16.99	16.71	16.11	13.07	11.3
Tangible Book Value per Share	11.38	14.21	12.89	12.84	12.4	11.36	12.72	11.36	10.64	10.93	10.74	10.82	7.7	5.44	4.58

Orthofix Medical Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)